Due to health issues, this site is no longer maintained and will be shut down shortly.

ENTX Entera Bio Ltd

Entera Bio Ltd is a biotechnology company specializing in the oral delivery of large molecules and biologics. It conducts clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics.

$1.03  -0.03 (-2.83%)
As of 03/24/2023 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  06/29/2018
Outstanding shares:  28,809,922
Average volume:  56,711
Market cap:   $30,538,517
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy